The impact of CYP2C19 genotype on phenoconversion by concomitant medication

被引：0
|
作者：
De Jong, Laura [1 ]
Boussallami, Soukayna [1 ]
Hawinkels, Luuk [4 ]
Hoekstra, Menno [1 ]
Tushuizen, Maarten [4 ]
Rissmann, Robert [3 ]
Swen, Jesse [2 ]
Manson, Martijn [1 ]
机构：
[1] Leiden Acad Ctr Drug Res, Div Syst Pharmacol & Pharm, Leiden, Netherlands
[2] Leiden Univ, Dept Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands
[3] Leiden Univ, Ctr Human Drug Res, Med Ctr, Leiden, Netherlands
[4] Leiden Univ, Dept Gastroenterol Hepatol, Med Ctr, Leiden, Netherlands
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0547
引用
收藏
页码：1326 / 1327
页数：2
相关论文
共 50 条
  • [21] Does CYP2C19 genotype affect clinical outcome?
    Jurriën M. ten Berg
    Vera H. Deneer
    Nature Reviews Cardiology, 2012, 9 : 192 - 194
  • [22] CYP2C19 GENOTYPE SIGNIFICANTLY AFFECTS THE PHARMACOKINETICS OF TOLPERISONE
    Byeon, J.
    Lee, H.
    Choi, C.
    Lee, Y.
    Jang, C.
    Bae, J.
    Lee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S23 - S24
  • [23] Dose of proton pump inhibitors and the CYP2C19 genotype
    Bertilsson, L
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2004, 95 (01) : 1 - 1
  • [24] Does CYP2C19 genotype affect clinical outcome?
    ten Berg, Jurrien M.
    Deneer, Vera H.
    NATURE REVIEWS CARDIOLOGY, 2012, 9 (04) : 192 - 194
  • [25] Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment
    Pare, Guillaume
    Mehta, Shamir R.
    Yusuf, Salim
    Anand, Sonia S.
    Connolly, Stuart J.
    Hirsh, Jack
    Simonsen, Katy
    Bhatt, Deepak L.
    Fox, Keith A. A.
    Eikelboom, John W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18): : 1704 - 1714
  • [26] CYP2C19 Genotype and Outcomes of Clopidogrel Treatment REPLY
    Pare, Guillaume
    Mehta, Shamir R.
    Eikelboom, John W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 482 - 482
  • [27] Allele and genotype frequency of CYP2C19 in a Tamilian population
    Adithan, C
    Gerard, N
    Vasu, S
    Rosemary, J
    Shashindran, CH
    Krishnamoorthy, R
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (03) : 331 - 333
  • [28] Effects of CYP2C19 genotype on tamoxifen and estrogen metabolism
    Gjerde, J.
    Geisler, J.
    Lundgren, S.
    Ekse, D.
    Varhaug, J. E.
    Mellgren, G.
    Steen, V. M.
    Lien, E. A.
    EJC SUPPLEMENTS, 2010, 8 (05): : 60 - 60
  • [29] DISTRIBUTION OF THE CYP2C19*2, CYP2C19*3 AND CYP2C19*4 GENE VARIANTS IN A ROMANIAN POPULATION
    Buzoianu, A. D.
    Trifa, A. P.
    Popp, R. A.
    Militaru, C. F.
    Bocsan, C., I
    Popp, I., V
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 80 - 80
  • [30] The effect of the CYP2C19*2 heterozygote genotype on the pharmacokinetics of nelfinavir
    Burger, David M.
    Schwietert, H. Reinier
    Colbers, E. P. H. Angela
    Becker, Mark
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (02) : 250 - 252
12345